Everest Organics Hits New 52-Week High of Rs.490, Marking Significant Milestone

2 hours ago
share
Share Via
Everest Organics has reached a new 52-week high, touching Rs.490 today, reflecting a notable surge in its stock price and marking a key milestone for the Pharmaceuticals & Biotechnology company. This achievement underscores the stock’s strong momentum amid a volatile trading session.



Stock Performance and Market Context


On 9 December 2025, Everest Organics recorded an intraday high of Rs.490, setting a fresh all-time peak for the stock. Despite opening with a gap down of 5.25%, the share price demonstrated resilience by rallying throughout the day, ultimately outperforming its sector by 3.67%. The stock’s intraday volatility was measured at 6.41%, indicating significant price fluctuations during trading hours.


The stock’s day low was Rs.431, while the closing price reflected a positive day change of 3.54%. Everest Organics has been on a three-day consecutive gain streak, delivering a cumulative return of 14.42% over this period. This sustained upward movement highlights the stock’s robust momentum in recent sessions.



Technical Indicators and Moving Averages


Everest Organics is currently trading above its key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This positioning suggests a strong technical foundation supporting the stock’s recent price action. The alignment of these moving averages often signals positive market sentiment and can act as support levels in case of any pullbacks.



Comparative Market Performance


In contrast to Everest Organics’ notable price movement, the broader market showed a more subdued performance. The Sensex opened lower at 84,742.87, down by 359.82 points or 0.42%, and was trading marginally down at 84,764.96 during the day. The index remains 1.64% below its own 52-week high of 86,159.02. Small-cap stocks led the market rally, with the BSE Small Cap index gaining 0.39%, reflecting selective strength in smaller companies.


Over the past year, Everest Organics has delivered a remarkable total return of 165.80%, significantly outpacing the Sensex’s 3.99% performance. This stark contrast highlights the stock’s exceptional growth trajectory within the Pharmaceuticals & Biotechnology sector.




Crushing the market! This Small Cap from Aerospace & Defense just earned its spot in our Top 1% with impressive gains. Don't let this opportunity slip through your hands.



  • - Recent Top 1% qualifier

  • - Impressive market performance

  • - Sector leader


See What's Driving the Rally →




Price Range and Volatility Insights


The stock’s 52-week low stands at Rs.152, illustrating a substantial price appreciation over the past year. The current high of Rs.490 represents more than a threefold increase from that low point, underscoring the stock’s strong upward trajectory. The high intraday volatility observed today reflects active trading interest and dynamic price discovery in the market.



Sector and Industry Positioning


Everest Organics operates within the Pharmaceuticals & Biotechnology sector, a space that has witnessed varied performance across companies. The stock’s ability to outperform its sector peers during the trading session indicates relative strength and investor focus on its recent developments. Trading above all major moving averages further supports the stock’s technical robustness within its industry group.




Why settle for Everest Organics ? SwitchER evaluates this Pharmaceuticals & Biotechnology micro-cap against peers, other sectors, and market caps to find you superior investment opportunities!



  • - Comprehensive evaluation done

  • - Superior opportunities identified

  • - Smart switching enabled


Discover Superior Stocks →




Summary of Key Metrics


To summarise, Everest Organics’ stock price reached Rs.490 today, marking a new 52-week and all-time high. The stock’s performance over the last three days has yielded a 14.42% return, with a day change of 3.54% on the latest trading session. The stock’s trading above all major moving averages and its significant outperformance relative to the Sensex and sector peers highlight its current market strength.


While the broader market experienced a modest decline, Everest Organics demonstrated resilience and upward momentum, reflecting a noteworthy development for the company’s equity performance in the Pharmaceuticals & Biotechnology sector.






{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News